Emergency Action is Necessary to Provide Payment for Pharmacist Prescribing of Paxlovid

APhA needs your assistance to ensure you can effectively care for you patients. Reach out to your Member of Congress and Senators and ask them to take immediate action to provide adequate, appropriate, and fair payment for pharmacist consultations and services for prescribing Paxlovid.

Act now  

APhA’s Learning Library

We’re excited to announce the launch of the new APhA Learning Library! This new platform will make it easier than ever for you to get the education you need. Read about some key highlights of our new system.

Learn more  

Community Pharmacy Workplace Summit

APhA is committed to facilitating meaningful dialogue between pharmacy management, pharmacy team members, and other stakeholders that result in improved workplaces, well-being, and ability to meet ethical obligations to patient safety.

Learn more  

Featured Education

Upcoming Events

Practice Resources

Tools and resources to support your practice

Access Now  


Latest from APhA

View CEO Blog

Ilisa Bernstein's Letter to the FDA Regarding Pharmacists Prescribing Oral COVID-19 Treatments

A letter from Interim CEO Ilisa Bernstein, PharmD, JD, FAPhA, to Dr. Robert Califf, Commissioner of the Food and Drug Administration (FDA), on the importance of pharmacists being allowed to prescribe oral COVID-19 treatments.


Breaking: APhA issues statement in response to Supreme Court’s Dobbs v Jackson decision

(July 25, 2022) WASHINGTON, DC— For the past month, the American Pharmacists Association (APhA) has been advocating for patients and pharmacists regarding the Dobbs v Jackson Supreme Court decision. This work has included engaging with members


Pharmacy news

View all news

Study shows widespread mislabeling of CBD OTC products

Researchers at Johns Hopkins University School of Medicine tested more than 100 topical cannabidiol (CBD) products available online and at stores, finding that the labels of many of these OTC products inaccurately listed their CBD content.

CDC: Higher overdose death rates among Blacks, Native Americans reflect treatment disparities

Fatal drug overdoses in the United States soared 30% in 2020, the most recent CDC statistics show, but the burden on minority populations has grown exponentially due to fewer treatment options.